Exponent Inc (EXPO)
95.93
+0.88
(+0.93%)
USD |
NASDAQ |
Nov 21, 16:00
95.93
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.870B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 23.43% |
| Valuation | |
| PE Ratio | 46.34 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 9.073 |
| Price to Book Value | 11.87 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.28 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 42.46% |
Profile
| Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America. |
| URL | https://www.exponent.com |
| Investor Relations URL | https://investors.exponent.com/investors/overview/default.aspx |
| HQ State/Province | California |
| Sector | Industrials |
| Industry | Professional Services |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Jan. 31, 2025 (est.) |
| Last Earnings Release | Oct. 24, 2024 |
| Next Ex-Dividend Date | Dec. 06, 2024 |
| Last Ex-Dividend Date | Sep. 06, 2024 |
Ratings
Profile
| Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America. |
| URL | https://www.exponent.com |
| Investor Relations URL | https://investors.exponent.com/investors/overview/default.aspx |
| HQ State/Province | California |
| Sector | Industrials |
| Industry | Professional Services |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Jan. 31, 2025 (est.) |
| Last Earnings Release | Oct. 24, 2024 |
| Next Ex-Dividend Date | Dec. 06, 2024 |
| Last Ex-Dividend Date | Sep. 06, 2024 |